Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The Src inhibitor AZD0530 demonstrates enhanced antiproliferative and anti-invasive activity in MUC16(+) A2780 ovarian carcinoma cells
    Meeting Abstract

    dos Santos, L. A.; Diaz, J. P.; Ma, X.; Thapi, D.; Yan, X. J.; Rosales, N.; Spriggs, D. R.
    Gynecologic Oncology (2008)

    Fulltext@MSK | Save
  • The MUC16/CA125 gene inhibits apoptosis in SK-OV-3 ovarian carcinoma cells
    Meeting Abstract

    Diaz, J. P.; dos Santos, L. A.; Rosales, N.; Thapi, D.; Ma, X.; Yan, X. J.; Spriggs, D. R.
    Gynecologic Oncology (2008)

    Fulltext@MSK | Save
  • Dasatinib is associated with durable treatment responses in chronic phase chronic myeloid leukemia: Long-term follow-up from the phase I trial (Ca180002)
    Meeting Abstract

    Cortes, J.; Sawyers, C. L.; Kantarjian, H. M.; Shah, N. P.; Paquette, R.; Bleickardt, E.; Paliwal, P.; Talpaz, M.
    Haematologica (2008)

    Fulltext@MSK | Save
  • CHED 886-P-glycoprotein independent resistance to oxidative stress in leukemia cells
    Meeting Abstract

    Clark, E. T.; Silverman, J. R.; Seideman, J.; Scheinberg, D. A.; Weisburg, J. H.
    Abstracts of Papers of the American Chemical Society (2008)

    Fulltext@MSK | Save
  • Regulatory T cells expanded by autologous mature human dendritic cells expressing indoleamine 2,3-dioxygenase are potent suppressors of T cell proliferation
    Meeting Abstract

    Chung, D. J.; Rossi, M.; Romano, E.; Pressley, J.; Antczak, C.; Munn, D. H.; Young, J. W.
    Blood (2008)

    Fulltext@MSK | Save
  • Purine-scaffold HSP90 inhibitors: The journey from a designed lead to a clinical candidate
    Meeting Abstract

    Chiosis, G.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • MEDI 188-Hsp90 inhibitors: The journey from a designed lead to a clinical candidate
    Meeting Abstract

    Chiosis, G.
    Abstracts of Papers of the American Chemical Society (2008)

    Fulltext@MSK | Save
  • Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplantation depends on transplantation conditioning intensity
    Meeting Abstract

    Brunstein, C.; Wagner, J. E.; Weisdorf, D.; Cooley, S.; Noreen, H.; Barker, J.; Defor, T.; Verrieris, M.; McGlave, P. B.; Blazar, B. R.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Targeting the molecular chaperone Hsp90 as a novel chemotherapeutic strategy for hepatocellular carcinoma (HCC)
    Meeting Abstract

    Breinig, M.; Goeppert, B.; Malz, M.; Schir-Macher, P.; Chiosis, G.; Kern, M. A.
    Hepatology (2008)

    Fulltext@MSK | Save
  • Targeting the molecular chaperone Hsp90 as a novel chemotherapeutic strategy for hepatocellular carcinoma (HCC)
    Meeting Abstract

    Breinig, M.; Goeppert, B.; Malz, M.; Schirmacher, P.; Chiosis, G.; Kern, M. A.
    Hepatology (2008)

    Fulltext@MSK | Save